chr6-157896831-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_016224.5(SNX9):c.305G>A(p.Gly102Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000201 in 1,612,510 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016224.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SNX9 | NM_016224.5 | c.305G>A | p.Gly102Asp | missense_variant | 5/18 | ENST00000392185.8 | |
SNX9 | XM_011535886.4 | c.23G>A | p.Gly8Asp | missense_variant | 2/15 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SNX9 | ENST00000392185.8 | c.305G>A | p.Gly102Asp | missense_variant | 5/18 | 1 | NM_016224.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000243 AC: 37AN: 152198Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000353 AC: 88AN: 249256Hom.: 1 AF XY: 0.000386 AC XY: 52AN XY: 134814
GnomAD4 exome AF: 0.000197 AC: 287AN: 1460194Hom.: 1 Cov.: 31 AF XY: 0.000211 AC XY: 153AN XY: 726452
GnomAD4 genome AF: 0.000243 AC: 37AN: 152316Hom.: 0 Cov.: 32 AF XY: 0.000309 AC XY: 23AN XY: 74472
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 23, 2021 | The c.305G>A (p.G102D) alteration is located in exon 5 (coding exon 5) of the SNX9 gene. This alteration results from a G to A substitution at nucleotide position 305, causing the glycine (G) at amino acid position 102 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at